167 related articles for article (PubMed ID: 35258665)
1. Hydrochlorothiazide use is associated with the risk of cutaneous and lip squamous cell carcinoma: A systematic review and meta-analysis.
de Macedo Andrade AC; Felix FA; França GM; Ribeiro ILA; Barboza CAG; de Castro RD; de Lisboa Lopes Costa A
Eur J Clin Pharmacol; 2022 Jun; 78(6):919-930. PubMed ID: 35258665
[TBL] [Abstract][Full Text] [Related]
2. Risk of squamous cell carcinoma of the lip and cutaneous melanoma in older Australians using hydrochlorothiazide: A population-based case-control study.
Daniels B; Pearson SA; Vajdic CM; Pottegård A; Buckley NA; Zoega H
Basic Clin Pharmacol Toxicol; 2020 Oct; 127(4):320-328. PubMed ID: 32608576
[TBL] [Abstract][Full Text] [Related]
3. Does hydrochlorothiazide increase the incidence of skin, lip and oral cancer in a UK population?
Carney K; Cousins M
Evid Based Dent; 2022 Mar; 23(1):38-39. PubMed ID: 35338330
[TBL] [Abstract][Full Text] [Related]
4. Hydrochlorothiazide use is strongly associated with risk of lip cancer.
Pottegård A; Hallas J; Olesen M; Svendsen MT; Habel LA; Friedman GD; Friis S
J Intern Med; 2017 Oct; 282(4):322-331. PubMed ID: 28480532
[TBL] [Abstract][Full Text] [Related]
5. Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark.
Pedersen SA; Gaist D; Schmidt SAJ; Hölmich LR; Friis S; Pottegård A
J Am Acad Dermatol; 2018 Apr; 78(4):673-681.e9. PubMed ID: 29217346
[TBL] [Abstract][Full Text] [Related]
6. Risk of Nonmelanoma Skin Cancer in Association With Use of Hydrochlorothiazide-Containing Products in the United States.
Eworuke E; Haug N; Bradley M; Cosgrove A; Zhang T; Dee EC; Adimadhyam S; Petrone A; Lee H; Woodworth T; Toh S
JNCI Cancer Spectr; 2021 Apr; 5(2):. PubMed ID: 33733052
[TBL] [Abstract][Full Text] [Related]
7. Use of hydrochlorothiazide and risk of skin cancer: a nationwide Taiwanese case-control study.
Pottegård A; Pedersen SA; Schmidt SAJ; Lee CN; Hsu CK; Liao TC; Shao SC; Lai EC
Br J Cancer; 2019 Nov; 121(11):973-978. PubMed ID: 31673105
[TBL] [Abstract][Full Text] [Related]
8. Association between Use of Hydrochlorothiazide and Risk of Keratinocyte Cancers in Kidney Transplant Recipients.
Letellier T; Leborgne F; Kerleau C; Gaultier A; Dantal J; Ville S;
Clin J Am Soc Nephrol; 2020 Dec; 15(12):1804-1813. PubMed ID: 33172936
[TBL] [Abstract][Full Text] [Related]
9. Association between hydrochlorothiazide and the risk of in situ and invasive squamous cell skin carcinoma and basal cell carcinoma: A population-based case-control study.
Adalsteinsson JA; Muzumdar S; Waldman R; Hu C; Wu R; Ratner D; Ungar J; Silverberg JI; Olafsdottir GH; Kristjansson AK; Tryggvadottir L; Jonasson JG
J Am Acad Dermatol; 2021 Mar; 84(3):669-675. PubMed ID: 32791082
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of non-melanoma skin cancers of the cutaneous perioral and vermilion lip treated by Mohs micrographic surgery.
Queen D; Knackstedt T; Polacco MA; Collins LK; Lee K; Samie FH
J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):305-311. PubMed ID: 30284728
[TBL] [Abstract][Full Text] [Related]
11. Association between hydrochlorothiazide exposure and different incident skin, lip and oral cavity cancers: A series of population-based nested case-control studies.
Morales DR; Pacurariu A; Slattery J; Kurz X
Br J Clin Pharmacol; 2020 Jul; 86(7):1336-1345. PubMed ID: 32068906
[TBL] [Abstract][Full Text] [Related]
12. The Risk of Cutaneous Squamous Cell Carcinoma Among Patients with Type 2 Diabetes Receiving Hydrochlorothiazide: A Cohort Study.
de Haan-Du J; Landman GWD; Groenier KH; Vissers PAJ; Louwman MWJ; Kleefstra N; de Bock GH
Cancer Epidemiol Biomarkers Prev; 2021 Nov; 30(11):2114-2121. PubMed ID: 34493493
[TBL] [Abstract][Full Text] [Related]
13. [Hydrochlorothiazide use and risk of skin cancers: A systematic review].
Becquart O; Guillot B; Bourrain JL; Duflos C; Du-Thanh A
Rev Med Interne; 2019 Sep; 40(9):617-622. PubMed ID: 31101331
[TBL] [Abstract][Full Text] [Related]
14. Hydrochlorothiazide Use and Skin Cancer: A Mohs Surgeon's Concern.
Cognetta AB; Wolfe CM; Heinrichs E
Dermatol Surg; 2016 Sep; 42(9):1107-9. PubMed ID: 27243134
[No Abstract] [Full Text] [Related]
15. Chronic Use of Hydrochlorothiazide and Risk of Skin Cancer in Caucasian Adults: A PharmLines Initiative Inception Cohort Study.
Haisma MS; Greven N; Logendran M; Bos J; van der Vegt B; Horváth B; De Vos S; De Bock GH; Hak E; Rácz E
Acta Derm Venereol; 2023 Apr; 103():adv3933. PubMed ID: 37014269
[TBL] [Abstract][Full Text] [Related]
16. Significant differences in nonmelanoma skin cancers of the upper and lower lip.
Dawn A; Lawrence N
Dermatol Surg; 2013 Aug; 39(8):1252-7. PubMed ID: 23725539
[TBL] [Abstract][Full Text] [Related]
17. Associations of thiazide use with skin cancers: a systematic review and meta-analysis.
Shao SC; Lai CC; Chen YH; Lai EC; Hung MJ; Chi CC
BMC Med; 2022 Jul; 20(1):228. PubMed ID: 35794547
[TBL] [Abstract][Full Text] [Related]
18. Is there a Link between Non Melanoma Skin Cancer and Hydrochlorothiazide?
Gallelli L; Cione E; Siniscalchi A; Vasta G; Guerra A; Scaramuzzino A; Longo L; Muraca L; De Sarro G; G Sp Working Group ; Leuzzi G; Gerace A; Scuteri A; Vasapollo P; Natale V; Zampogna S; Luciani F
Curr Drug Saf; 2022; 17(3):211-216. PubMed ID: 34732119
[TBL] [Abstract][Full Text] [Related]
19. Use of Hydrochlorothiazide and Risk of Melanoma and Nonmelanoma Skin Cancer.
Rouette J; Yin H; Pottegård A; Nirantharakumar K; Azoulay L
Drug Saf; 2021 Feb; 44(2):245-254. PubMed ID: 33104975
[TBL] [Abstract][Full Text] [Related]
20. Increased cutaneous squamous cell carcinoma risk with hydrochlorothiazide use: is there a safe alternative?
Hollestein LM; Arnspang Pedersen S
Br J Dermatol; 2021 Aug; 185(2):244-245. PubMed ID: 34224145
[No Abstract] [Full Text] [Related]
[Next] [New Search]
